CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 114 filers reported holding CHEMOCENTRYX INC in Q2 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,014,000 | +92.4% | 38,984 | -7.7% | 0.02% | +90.0% |
| Q2 2022 | $1,047,000 | -42.6% | 42,238 | -42.0% | 0.01% | -50.0% |
| Q1 2022 | $1,825,000 | -38.2% | 72,802 | -10.2% | 0.02% | -39.4% |
| Q4 2021 | $2,951,000 | +101.4% | 81,040 | -5.4% | 0.03% | +135.7% |
| Q3 2021 | $1,465,000 | +19.1% | 85,678 | -6.7% | 0.01% | +27.3% |
| Q2 2021 | $1,230,000 | -80.9% | 91,864 | -27.1% | 0.01% | -82.5% |
| Q1 2021 | $6,453,000 | -16.3% | 125,942 | +1.1% | 0.06% | -27.6% |
| Q4 2020 | $7,710,000 | +60.2% | 124,523 | +41.7% | 0.09% | +22.5% |
| Q3 2020 | $4,814,000 | -0.8% | 87,853 | +4.1% | 0.07% | +9.2% |
| Q2 2020 | $4,855,000 | +14.4% | 84,380 | -20.1% | 0.06% | -1.5% |
| Q1 2020 | $4,245,000 | -8.5% | 105,638 | -9.9% | 0.07% | +83.3% |
| Q4 2019 | $4,639,000 | +489.5% | 117,288 | +1.0% | 0.04% | +500.0% |
| Q3 2019 | $787,000 | -30.4% | 116,109 | -4.4% | 0.01% | -25.0% |
| Q2 2019 | $1,130,000 | -33.3% | 121,493 | -0.4% | 0.01% | -33.3% |
| Q1 2019 | $1,695,000 | -0.8% | 122,039 | -22.0% | 0.01% | -7.7% |
| Q4 2018 | $1,708,000 | +3.2% | 156,559 | +19.6% | 0.01% | +18.2% |
| Q3 2018 | $1,655,000 | +17.2% | 130,929 | +22.1% | 0.01% | +22.2% |
| Q2 2018 | $1,412,000 | +176.3% | 107,231 | +185.3% | 0.01% | +125.0% |
| Q1 2018 | $511,000 | +70.9% | 37,591 | -8.6% | 0.00% | +100.0% |
| Q1 2017 | $299,000 | -12.1% | 41,127 | -10.5% | 0.00% | -33.3% |
| Q4 2016 | $340,000 | – | 45,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |